Rite Aid's new beginning: an interview with CEO Matt Schroeder
Rite Aid's new CEO shares that the company will build on the retailer’s iconic brand and standing as a trusted health care provider.
Rite Aid's new CEO shares that the company will build on the retailer’s iconic brand and standing as a trusted health care provider.
Earn 100 bonus miles with just a $10 spend at participating Pharmasave locations.
Hy-Vee will also be hosting drive-thru flu shot clinics at all Hy-Vee Pharmacy locations.
"We welcome and encourage a national discussion about inflation, prices and the many factors that influence the economy, but this conversation must be informed by data and focused on solutions rather than politics.”
Company providing support to customers, patients, members and colleagues as Tropical Storm Francine moves in.
Move signals a significant shift towards clean ingredients and more transparent offerings in food, beauty and now, the medicine aisle.
The rule, which stems from Section 204(d) of the FDA’s Food Safety Modernization Act (FSMA), requires a robust tracking system for high-risk foods like fresh produce, deli salads, and certain seafood products.
“This report shows that the cost of swipe fees is much higher than previously known and that the impact on small businesses and consumers is far more severe.”
To facilitate the deal, Big Lots initiated Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware.
By leveraging dunnhumby’s advanced AI-powered platform, Family Dollar aims to refine its product offerings to match local shopping preferences, the companies say, ensuring that customers find exactly what they need at the right time.
In the past few months, several holdouts gave in to the Amazon juggernaut.
Economy is still growing slowly and inflation is under control.
“Our ability to attract and retain talent has always been key to our success, and we look forward to helping our new team members grow in their careers.”
New line is designed to give customers premium quality without the premium price tag.
The company lowered its outlook for the full fiscal year.
The 2024-2025 vaccines protect against the dominant KP.2 COVID-19 variant by lowering the risk of infection and preventing severe disease, hospitalization, and death.